SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 273 filers reported holding SAGE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $397,000 | -9.4% | 4,592 | -36.0% | 0.05% | -21.0% |
| Q3 2020 | $438,000 | +57.0% | 7,170 | +6.7% | 0.06% | +40.9% |
| Q2 2020 | $279,000 | +121.4% | 6,720 | +53.1% | 0.04% | +76.0% |
| Q1 2020 | $126,000 | -30.0% | 4,390 | +75.6% | 0.02% | -13.8% |
| Q4 2019 | $180,000 | -15.5% | 2,500 | +64.5% | 0.03% | -21.6% |
| Q3 2019 | $213,000 | +475.7% | 1,520 | +284.8% | 0.04% | +311.1% |
| Q4 2018 | $37,000 | -33.9% | 395 | 0.0% | 0.01% | -25.0% |
| Q3 2018 | $56,000 | – | 395 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |